MRK
Merck & Co., Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$145.97
+0.53%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$146.96
From 52W high−6.70%
Volume11.10M
Market cap$360.12B
P/E (TTM)115.8x
P/S (TTM)5.4x
Div yield2.33%
Key dataOct 16, 2026
Open
$146.96
From 52W high
−6.70%
Volume
11.10M
Market cap
$360.12B
ValuationView details →
P/E (Fwd)
16.9x
EV/EBITDA
29.2x
P/E (TTM)
115.8x
RSI (14)
53.5
MomentumView details →
1D Return
+0.53%
YTD Return
+39.58%
SummaryUpdated Jun 1, 2026
Merck & Co., Inc. (NYSE:MRK) is one of the world's largest pharmaceutical companies, founded in 1891 and headquartered in Kenilworth, New Jersey. Originally established as the American subsidiary of the German chemical company E. Merck, the company became independent during World War I and has since evolved into a global healthcare leader. Today, Merck operates as a diversified healthcare company serving patients worldwide through two primary business segments: pharmaceuticals for human health and animal health products. The company has built its reputation on developing breakthrough medicines and vaccines that address some of the most challenging diseases facing humanity.
Similar companies
Latest newsMore news →
Merck & Co., Inc. reported $18.8 billion in US revenue for Keytruda in 2025 and $22.5 billion in profits, up 16% from 2024.2h agoTechnology shares fell in Thursday premarket trading, including CoreWeave, Inc. down about 5%, ORACLE CORP down about 2%, MICRON TECHNOLOGY INC down nearly 4%, ADVANCED MICRO DEVICES INC down more than 2%, and NVIDIA CORP down around 2%; Walmart Inc. gained about 3% and Merck & Co., Inc. advanced more than 1%.1d ago